Aclaris Therapeutics, Inc.’s ACRS share price has surged by 6.72%, which has investors questioning if this is right time to sell.

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Kymera Therapeutics, Inc.’s KYMR share price has surged by 5.21%, which has investors questioning if this is right time to sell.

Complete BiomX Inc. stock information by Barron's. View real-time PHGE stock price and news, along with industry-best analysis.

Children with early-onset atopic dermatitis (AD) have an elevated risk for pediatric uveitis, according to a study published ...

BiomX Inc. research and ratings by Barron's. View PHGE revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

A new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...

We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are ...

In adults with atopic dermatitis, moisturizers with anti-inflammatory ingredients significantly improved skin hydration and ...

On Tuesday morning, Galderma launched its Scratch Resistance campaign to highlight one of the most difficult symptoms of ...